These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33766958)

  • 1. Successful use of intravenous treprostinil as a bridge to pulmonary thromboendarterectomy.
    Cattran A; Elwing J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33766958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension.
    Bresser P; Fedullo PF; Auger WR; Channick RN; Robbins IM; Kerr KM; Jamieson SW; Rubin LJ
    Eur Respir J; 2004 Apr; 23(4):595-600. PubMed ID: 15083760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bilateral pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: the youngest case in our region].
    Olguntürk R; Çevik A; Kula S; Yıldızeli B
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):340-2. PubMed ID: 23760123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension.
    Skoro-Sajer N; Bonderman D; Wiesbauer F; Harja E; Jakowitsch J; Klepetko W; Kneussl MP; Lang IM
    J Thromb Haemost; 2007 Mar; 5(3):483-9. PubMed ID: 17319903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
    Zhang Y; Yu X; Jin Q; Luo Q; Zhao Z; Zhao Q; Yan L; Liu Z
    Heart Fail Rev; 2019 Nov; 24(6):949-965. PubMed ID: 31044326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty.
    Fernandes TM; Poch DS; Auger WR
    Methodist Debakey Cardiovasc J; 2016; 12(4):205-212. PubMed ID: 28289495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
    Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
    Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition of Intravenous Treprostinil to Oral Therapy in a Patient with Functional Class IV Chronic Thromboembolic Pulmonary Hypertension.
    Thurber KM; Williams BM; Bates RE; Frantz RP
    Pharmacotherapy; 2017 Aug; 37(8):e76-e81. PubMed ID: 28513869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Thromboembolic Pulmonary Hypertension: Evolving Therapeutic Approaches for Operable and Inoperable Disease.
    Mahmud E; Madani MM; Kim NH; Poch D; Ang L; Behnamfar O; Patel MP; Auger WR
    J Am Coll Cardiol; 2018 May; 71(21):2468-2486. PubMed ID: 29793636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension.
    Nagaya N; Sasaki N; Ando M; Ogino H; Sakamaki F; Kyotani S; Nakanishi N
    Chest; 2003 Feb; 123(2):338-43. PubMed ID: 12576349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Thromboembolic Pulmonary Hypertension: A Comprehensive Review and Multidisciplinary Approach to Surgical Treatment.
    Al Abri Q; Lu AJ; Ramchandani MK
    Methodist Debakey Cardiovasc J; 2021; 17(2):e18-e28. PubMed ID: 34377353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Thromboembolic Pulmonary Hypertension Medical Management.
    Logue R; Safdar Z
    Methodist Debakey Cardiovasc J; 2021; 17(2):e29-e33. PubMed ID: 34306521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
    Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
    J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary thromboendarterectomy is a curative resolution for chronic thromboembolic pulmonary hypertension associated with antiphospholipid syndrome: a retrospective cohort study.
    Li C; Zhao J; Liu S; Song W; Zhu J; Hua L; Wang Q; Li M; Zeng X; Zhao Y
    Lupus; 2018 Dec; 27(14):2206-2214. PubMed ID: 30451640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How should a physician approach the pharmacological management of chronic thromboembolic pulmonary hypertension?
    Tian Z; Jiang X; Jing ZC
    Expert Opin Pharmacother; 2021 Apr; 22(5):557-563. PubMed ID: 33016151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial.
    Sadushi-Kolici R; Jansa P; Kopec G; Torbicki A; Skoro-Sajer N; Campean IA; Halank M; Simkova I; Karlocai K; Steringer-Mascherbauer R; Samarzija M; Salobir B; Klepetko W; Lindner J; Lang IM
    Lancet Respir Med; 2019 Mar; 7(3):239-248. PubMed ID: 30477763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Bishop BM
    Am J Health Syst Pharm; 2014 Nov; 71(21):1839-44. PubMed ID: 25320133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
    Kerr KM; Rubin LJ
    Chest; 2003 Feb; 123(2):319-20. PubMed ID: 12576339
    [No Abstract]   [Full Text] [Related]  

  • 19. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Benza RL; Langleben D; Hemnes AR; Vonk Noordegraaf A; Rosenkranz S; Thenappan T; Hassoun PM; Preston IR; Ghio S; Badagliacca R; Vizza CD; Lang IM; Meier C; Grünig E
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36198418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up.
    Kerr KM; Elliott CG; Chin K; Benza RL; Channick RN; Davis RD; He F; LaCroix A; Madani MM; McLaughlin VV; Park M; Robbins IM; Tapson VF; Terry JR; Test VJ; Jain S; Auger WR
    Chest; 2021 Nov; 160(5):1822-1831. PubMed ID: 34090871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.